Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis

Oncotarget

Volumn 4, Issue 8, 2013, Pages 1199-1211

  Lokman, Noor A ^a   Elder, Alison S F ^a   Ween, Miranda P ^b   Pyragius, Carmen E ^a   Hoffmann, Peter ^b   Oehler, Martin K ^a,c   Ricciardelli, Carmela ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Annexin A2; Chick chorioallantoic membrane assay; Invasion; Ovarian cancer; Xenograft model

Indexed keywords

LIPOCORTIN 2; NEUTRALIZING ANTIBODY; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENESIS; CELL ADHESION; CELL INTERACTION; CELL MOTILITY; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG TARGETING; EMBRYO; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MIGRATION INHIBITION; MOUSE; NONHUMAN; OVARY CANCER; OVARY CARCINOMA; PERITONEUM CELL; PERITONEUM METASTASIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; ANNEXIN A2; ANTIBODIES, NEUTRALIZING; CELL COMMUNICATION; CELL LINE, TUMOR; CHICK EMBRYO; COCULTURE TECHNIQUES; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; RNA, SMALL INTERFERING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84884336241     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1122     Document Type: Article

References (37)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2013. CA: A Cancer Journal for Clinicians. 2013; 63(1):11- 30.
2. Ween MP, Lokman NA, Hoffmann P, Rodgers RJ, Ricciardelli C, and Oehler MK. Transforming growth factorbeta- induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. Int J Cancer. 2011; 128(7):1570-1584.
3. Lokman NA, Ween MP, Oehler MK, and Ricciardelli C. The role of annexin A2 in tumorigenesis, and cancer progression. Cancer Microenviron. 2011; 4(2):199-208.
4. Mai J, Waisman DM, and Sloane BF. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim Biophys Acta 2000; 1477(1-2):215-230.
5. Oliferenko S, Paiha K, Harder T, Gerke V, Schwarzler C, Schwarz H, Beug H, Gunthert U, and Huber LA. Analysis of CD44-containing lipid rafts: Recruitment of annexin II, and stabilization by the actin cytoskeleton. J Cell Biol. 1999; 146(4):843-854.
6. Madureira PA, Hill R, Miller VA, Giacomantonio C, Lee PW, and Waisman DM. Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. Oncotarget. 2011; 2(12):1075-1093.
7. Cesarman GM, Guevara CA, and Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PAdependent plasminogen activation. J Biol Chem. 1994; 269(33):21198-21203.
8. Sharma M, Ownbey RT, and Sharma MC. Breast cancer cell surface annexin II induces cell migration, and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Path. 2010; 88(2):278-286.
9. Zhai H, Acharya S, Gravanis I, Mehmood S, Seidman RJ, Shroyer KR, Hajjar KA, and Tsirka SE. Annexin A2 promotes glioma cell invasion, and tumor progression. The Journal of Neuroscience. 2011; 31(40):14346-14360.
10. Zheng L, Foley K, Huang L, Leubner A, Mo G, Olino K, Edil BH, Mizuma M, Sharma R, and Le DT. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion, and metastases of pancreatic cancer. PLoS One. 2011; 6(4):e19390.
11. Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, and Sharma MC. Angiogenesis-associated protein annexin II in breast cancer: Selective expression in invasive breast cancer, and contribution to tumor invasion, and progression. Exp Mol Path. 2006; 81(2):146-156.
12. Zhao P, Zhang W, Tang J, Ma XK, Dai JY, Li Y, Jiang JL, Zhang SH, and Chen ZN. Annexin II promotes invasion, and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer science. 2010; 101(2):387-395.
13. Shiozawa Y, Havens AM, Jung Y, Ziegler AM, Pedersen EA, Wang J, Lu G, Roodman GD, Loberg RD, Pienta KJ, and Taichman RS. Annexin II/annexin II receptor axis regulates adhesion, migration, homing,, and growth of prostate cancer. J Cell Biochem. 2008; 105(2):370-380.
14. Sodek KL, Evangelou AI, Ignatchenko A, Agochiya M, Brown TJ, Ringuette MJ, Jurisica I, and Kislinger T. Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT). Mol Biosyst. 2008; 4(7):762-773.
15. Bengtsson S, Krogh M, Szigyarto CA-K, Uhlen M, Schedvins K, Silfverswärd C, Linder S, Auer G, Alaiya A, and James P. Large-Scale Proteomics Analysis of Human Ovarian Cancer for Biomarkers. Journal of Proteome Research. 2007; 6(4):1440-1450.
16. Diaz VM, Hurtado M, Thomson TM, Reventos J, and Paciucci R. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen, and promotes invasion in vitro. Gut. 2004; 53(7):993-1000.
17. Duncan R, Carpenter B, Main LC, Telfer C, and Murray GI. Characterisation, and protein expression profiling of annexins in colorectal cancer. British Journal of Cancer. 2008; 98(2):426-433.
18. Shetty PK, Thamake SI, Biswas S, Johansson SL, and Vishwanatha JK. Reciprocal Regulation of Annexin A2, and EGFR with Her-2 in Her-2 Negative, and Herceptin- Resistant Breast Cancer. PLoS One. 2012; 7(9):e44299.
19. Sun Y, Gao G, Cai J, Wang Y, Qu X, He L, Liu F, Zhang Y, Lin K, and Ma S. Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma. Carcinogenesis. 2013; 34(3):595-604.
20. Reeves SA, Chavez-Kappel C, Davis R, Rosenblum M, and Israel MA. Developmental Regulation of Annexin II (Lipocortin 2) in Human Brain, and Expression in High Grade Glioma. Cancer Res. 1992; 52(24):6871-6876.
21. Deryugina EI, and Quigley JP. Cell Surface Remodeling by Plasmin: A New Function for an Old Enzyme. Journal of Biomedicine, and Biotechnology. 2012; 2012.
22. Laumonnier Y, Syrovets T, Burysek L, and Simmet T. Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood. 2006; 107(8):3342-3349.
23. Hajjar KA, Jacovina AT, and Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem. 1994; 269(33):21191- 21197.
24. Wang CY, Lin YS, Su WC, Chen CL, and Lin CF. Glycogen Synthase Kinase-3, and Omi/HtrA2 Induce Annexin A2 Cleavage followed by Cell Cycle Inhibition, and Apoptosis. Mol Biol Cell. 2009; 20(19):4153-4161.
25. Tsunezumi J, Yamamoto K, Higashi S, and Miyazaki K. Matrilysin (matrix metalloprotease-7) cleaves membranebound annexin II, and enhances binding of tissue-typeplasminogen activator to cancer cell surfaces. FEBS J. 2008; 275(19):4810-4823.
26. Chen J, He QY, Yuen AP, and Chiu JF. Proteomics of buccal squamous cell carcinoma: The involvement of multiple pathways in tumorigenesis. Proteomics. 2004; 4(8):2465-2475.
27. Nedjadi T, Kitteringham N, Campbell F, Jenkins RE, Park BK, Navarro P, Ashcroft F, Tepikin A, Neoptolemos JP, and Costello E. S100A6 binds to annexin 2 in pancreatic cancer cells, and promotes pancreatic cancer cell motility. Br J Cancer. 2009; 101(7):1145-1154.
28. Zhang J, Guo B, Zhang Y, Cao J, and Chen T. Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc,, and plasmin, and inhibits breast cancer cell proliferation, and invasion. Saudi Med J. 2010; 31(4):374- 381.
29. Braden AR, Kafka MT, Cunningham L, Jones H, and Vishwanatha JK. Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth. J Nanosci Nanotechnol. 2009; 9(5):2856-2865.
30. Jung Y, Wang J, Song J, Shiozawa Y, Havens A, Wang Z, Sun YX, Emerson SG, Krebsbach PH, and Taichman RS. Annexin II expressed by osteoblasts, and endothelial cells regulates stem cell adhesion, homing,, and engraftment following transplantation. Blood. 2007; 110(1):82-90.
31. Brownstein C, Falcone D, Jacovina A, and Hajjar K. Annexin II ; A Mediator of Cell Surface-Specific Plasmin Generation. Annals of the New York Academy of Sciences. 2001; 947:143-156.
32. Sharma M, Blackman MR, and Sharma MC. Antibodydirected neutralization of annexin II (ANX II) inhibits neoangiogenesis, and human breast tumor growth in a xenograft model. Experimental, and Molecular Pathology. 2012; 92(1):175-184.
33. Sharma MR, Rothman V, Tuszynski GP, and Sharma MC. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: Possible biochemical mechanism of angiostatin's action. Exp Mol Path. 2006; 81(2):136-145.
34. Inokuchi J, Narula N, Yee DS, Skarecky DW, Lau A, Ornstein DK, and Tyson DR. Annexin A2 positively contributes to the malignant phenotype, and secretion of IL-6 in DU145 prostate cancer cells. Int J Cancer. 2009; 124(1):68-74.
35. Ricciardelli C, Frewin KM, Tan Ide A, Williams ED, Opeskin K, Pritchard MA, Ingman WV, and Russell DL. The ADAMTS1 protease gene is required for mammary tumor growth, and metastasis. Am J Pathol. 2011; 179(6):3075-3085.
36. Ween MP, Hummitzsch K, Rodgers RJ, Oehler MK, and Ricciardelli C. Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides. Clin Exp Metastasis. 2011; 28(2):113-125.
37. Lokman NA, Elder AS, Ricciardelli C, and Oehler MK. Chick Chorioallantoic Membrane (CAM) Assay as an In Vivo Model to Study the Effect of Newly Identified Molecules on Ovarian Cancer Invasion, and Metastasis. Int J Mol Sci. 2012; 13(8):9959-9970.